Ondine Biomedical Inc (LON:OBIMF) | Finanzwire

Basculer en Français

8302	Companies
115125	Keywords
55448	Articles
62531	Press releases

Headlines Articles Press releases Ondine Biomedical Inc

Home
Companies
Ondine Biomedical Inc

BRIEF

published on 04/22/2024 at 08:05, 6 months 29 days ago

Ondine Biomedical Inc Introduces Steriwave Technology in Australia

Nasal Decolonization Steriwave Technology Ondine Biomedical Inc Hospital-acquired Infections Surgical Safety
PRESS RELEASE

published on 04/22/2024 at 08:00, 6 months 29 days ago

Ondine Biomedical Inc Announces Steriwave in First Australian Hospital
Mater Hospital, North Sydney is the first Australian hospital to implement Ondine Biomedical's light-activated antimicrobial technology, Steriwave®, for infection prevention

Ondine Biomedical Steriwave Technology Mater Hospital North Sydney Antimicrobial
BRIEF

published on 04/15/2024 at 08:05, 7 months 6 days ago

Ondine Biomedical Inc. Reports 32% Reduction in Surgical Infections with Steriwave

Antimicrobial Resistance Steriwave Healthcare Cost Savings Ondine Biomedical Inc Surgical Infections
PRESS RELEASE

published on 04/15/2024 at 08:00, 7 months 6 days ago

Ondine Biomedical Inc. Announces 32% Fewer SSIs After Steriwave Replaced Mupirocin
Study at Mazankowski Alberta Heart Institute shows 32% reduction in cardiac infections with Steriwave replacing antibiotic standard. Significant cost savings and high compliance. Expert commentary available

Steriwave Cost Savings Mazankowski Alberta Heart Institute Cardiac Infections Antimicrobial Treatment
BRIEF

published on 04/10/2024 at 08:05, 7 months 11 days ago

Ondine Biomedical Inc.'s Steriwave Cleared for Use in HCA Healthcare UK Facilities

Antimicrobial Resistance Steriwave Healthcare-associated Infections HCA Healthcare UK Antibiotic Reduction
PRESS RELEASE

published on 04/10/2024 at 08:00, 7 months 11 days ago

Ondine Biomedical Inc. Announces Steriwave Authorized for use by HCA UK
HCA UK authorizes Steriwave antimicrobial by Ondine Biomedical to combat healthcare-associated infections without inducing antimicrobial resistance. Approval allows wider adoption in healthcare facilities

Antimicrobial Resistance Healthcare Facilities Steriwave Ondine Biomedical HCA UK
BRIEF

published on 04/04/2024 at 08:05, 7 months 17 days ago

Ondine Biomedical Inc. Expands into ICU Market with Steriwave®

Antimicrobial Resistance Steriwave Ondine Biomedical Healthcare-associated Infections Intensive Care Unit
PRESS RELEASE

published on 04/04/2024 at 08:00, 7 months 17 days ago

Ondine Biomedical Inc. Announces Entry into ICU Market Expands Revenue Potential
Ondine Biomedical plans entry into ICU market following interest from Canadian Hospitals. The move aims to reduce infections with Steriwave® treatment without triggering antimicrobial resistance. Cost savings for hospitals expected

Antimicrobial Resistance Ondine Biomedical ICU Market Steriwave® Hospital Infections
BRIEF

published on 03/25/2024 at 08:05, 7 months 27 days ago

Ondine Biomedical Inc. Achieves Commercial Adoption of Steriwave in NHS Hospitals

Antimicrobial Resistance Ondine Biomedical Inc. Steriwave Surgical Site Infections NHS
PRESS RELEASE

published on 03/25/2024 at 08:00, 7 months 27 days ago

Ondine Biomedical Inc. Announces First commercial adoption of Steriwave by the NHS
NHS hospitals adopt groundbreaking light-activated antimicrobial, Steriwave, to combat AMR and reduce surgical infections. Ondine Biomedical partners with NHS for further adoption

Steriwave Ondine Biomedical NHS Hospitals Light-activated Antimicrobial Surgical Infections

Accesswire

Published on 11/22/2024 at 00:00, 17 minutes ago

Gratomic Announces Company and Operational Update
Published on 11/21/2024 at 22:05, 2 hours 12 minutes ago

Protagonist Announces Nomination of PN-881, a Potential Best-in-Class Oral Peptide IL-17 Antagonist Development Candidate
Published on 11/21/2024 at 21:50, 2 hours 27 minutes ago

Seventy Ninth Resources Announces Successful First Reconnaissance at McKellar Copper-Zinc and Enable Gold Projects
Published on 11/21/2024 at 20:15, 4 hours 2 minutes ago

Woodland Park Zoo Awarded Transformative Grant to Advance Empathy for Animals
Published on 11/21/2024 at 20:10, 4 hours 7 minutes ago

For Us TV Productions, a Portfolio Company of Belle Bonica Luxe Corp., Invites BIPOC Filmmakers and Producers to Join Its Inclusive Streaming Platform

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 19:01, 5 hours 16 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/21/2024 at 18:36, 5 hours 41 minutes ago

Original-Research: Beaconsmind AG (von First Berlin Equity Research GmbH): BUY
Published on 11/21/2024 at 17:58, 6 hours 18 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/21/2024 at 17:51, 6 hours 25 minutes ago

LIGHTON announces highly successful IPO on Euronext Growth Paris.
Published on 11/21/2024 at 17:51, 6 hours 26 minutes ago

2CRSi SA: 2CRSi supplies Exaion, a subsidiary of the EDF Group, with high-performance immersion servers in North America.

Les Echos

Published on 11/21/2024 at 06:58, 17 hours 19 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 1 day 4 hours ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 1 day 6 hours ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 1 day 6 hours ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 16 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE